India, Jan. 8 -- image credit- freepik

Addressing one of the most persistent barriers to advanced cancer care in India, Bengaluru-basedImmuneel Therapeuticshas recently announced strategic partnerships withImpact Guru, a leading healthcare crowdfunding platform, andCarePal Money, a healthcare-focused lending marketplace. The collaborations aim to significantly improve financial access to CAR T-cell therapy for patients across diverse socio-economic backgrounds.

CAR T-cell therapy is among the most advanced and personalised treatments available today for certain blood cancers, offering renewed hope to patients with relapsed or refractory disease. However, access to these therapies has been constrained by high upfront costs and limited fi...